Active Ingredient: AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
Proprietary Name: DYANAVEL XR
Dosage Form; Route of Administration: SUSPENSION, EXTENDED RELEASE; ORAL
Strength: 2MG/ML;EQ 0.5MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N208147
Product Number: 001
Approval Date: Oct 19, 2015
Applicant Holder Full Name: TRIS PHARMA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
